2-amino-5-phosphonovalerate has been researched along with clonazepam in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badiu, CI | 1 |
1 other study(ies) available for 2-amino-5-phosphonovalerate and clonazepam
Article | Year |
---|---|
Sensitivity of thalamic GABAergic currents to clonazepam does not differ between control and genetic absence epilepsy rats.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Anticonvulsants; Cadmium; Clonazepam; Disease Models, Animal; Drug Interactions; Electric Stimulation; Epilepsy, Absence; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Neural Inhibition; Neurons; Patch-Clamp Techniques; Rats; Rats, Mutant Strains; Synapses; Thalamus | 2004 |